A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Published:2013-12 Issue:4 Volume:12 Page:248-254
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Wainberg Zev A.,Messersmith Wells A.,Peddi Parvin F.,Kapp Amy V.,Ashkenazi Avi,Royer-Joo Stephanie,Portera Chia C.,Kozloff Mark F.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference24 articles.

1. Cancer Facts & Figures. Available at: http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2012. Accessed: December 6, 2012.

2. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study;Hochster;J Clin Oncol,2008

3. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study;Van Cutsem;Ann Oncol,2009

4. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists;Ashkenazi;Nat Rev Drug Discov,2008

5. Targeting death and decoy receptors of the tumour-necrosis factor superfamily;Ashkenazi;Nat Rev Cancer,2002

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer;Biomaterials;2025-01

2. Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors;Digestive Diseases and Sciences;2024-08-01

3. Collapsed Star Copolymers Exhibiting Near Perfect Mimicry of the Therapeutic Protein “TRAIL”;Journal of the American Chemical Society;2024-07-26

4. Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells;International Journal of Molecular Sciences;2023-07-25

5. Therapeutic targeting of TRAIL death receptors;Biochemical Society Transactions;2023-01-11